Laboratory Products 27


First 10-Colour, CE IVD Reagent for L&L Analysis Launched


Beckman Coulter Life Sciences further demonstrates its expertise in clinical flow cytometry with the launch of ClearLLab LS Lymphoid Screen Reagent,


Europe’s first CE-marked 10-colour, 12 antibody reagent combination for leukaemia and lymphoma analysis.


The ClearLLab LS Lymphoid Screen delivers greater confidence in results with a faster turnaround time. It eliminates 14 manual workflow steps, while streamlining five others; and is available through a dry unitised, ready to use formulation. ClearLLab has been specifically designed for the fast and accurate identification of haematolymphoid cell populations on the company’s Navios# flow cytometer.


Mario Koksch, Vice President and General Manager of Beckman Coulter’s Cytometry Business Unit said: “Beckman Coulter provides lab scientists with the tools they need to standardise and streamline workflow when using high content flow cytometry in clinical decision-making.”


.. rfect reaction.


.. ct reaction.


Dr Kosch explained: “If survival rates are to be improved, we need to be able to diagnose life-threatening haematolymphoid diseases as quickly as possible. With ClearLLab LS Lymphoid Screen, the lab now has the means to speed up the delivery of patient results to clinicians, while having added confidence in their accuracy.”


to reach 500,000 readers*


The ClearLLab LS Lymphoid Screen is the first of an advanced range of Beckman Coulter clinical flow cytometry products which will cater to different global workflow requirements over the next five years. It is compatible with the World Health Organization (WHO) 2008-revised classification of myeloid neoplasms and acute leukemia. WHO, in collaboration with the European Association for Haematopathology and the Society for Haematopathology, made important changes to the classification of these diseases, including new criteria for the recognition of some previously described neoplasms as well as clarification and refinement of the defining criteria for others.


*Average Pass-on rate = 3.2


The Navios delivers increased accuracy and resolution even for dim stains and quantitation, able to maintain a high yield of processed signals, more than 90%, even at 25,000 events per second. The instrument incorporates 12 detectors which include 10 fluorescence detectors and two light scattering detectors. Simultaneous measurements of integral, peak and width are available for all scatter measurements and up to 10 fluorescent parameters.


The ClearLLab product line also includes five panels of pre-mixed cocktails in liquid format for those customers carrying out flow cytometry characterisation of hematolymphoid neoplasia on Beckman Coulter’s FC 500 instrument.


40915pr@reply-direct.com each 500,000 readers*


Elongated Tip Portfolio Provides Safe and Contact-Free Pipetting


*Average Pass-on rate = 3.2 All the right elements...


or the neck of a the flask. Even minimal volumes can be recovered safely. These 5mL L tips are available in various purity grades and with Dualfilter.


Graduations on each 5mL L tip as well as on big volume tips of epT.I.P.S. 2.5mL, 5mL, 10mL and 10mL L, allow easy visual recognition and control of liquid level when pipetting. In combination with the Eppendorf pipettes like the Eppendorf Reference® Eppendorf Xplorer®


for a perfect reaction.


/Xplorer® 2, Eppendorf Research® plus,


plus excellent results will be achieved. 40049pr@reply-direct.com


Print, Online and Digital Media combined to reach 500,000 readers* *Average Pass-on rate = 3.2


elongated tip portfolio with a long- distance tip. The new pipette tips epT.I.P.S. 5mL L and ep Dualfilter T.I.P.S. 5mL L with a length of 175 mm easily reach the bottom of the new Eppendorf Conical Tubes 15mL or graduated flasks, avoiding sample loss or cross contamination of pipette and vessel. The long and slim design of this new elongated 5mL tips give free access to the sample with reduced risk of touching the sides of tubes


Once again, Eppendorf completes the epT.I.P.S.®


Extensive Offering for Cryogenic Sample Homogenisation


Reproducible grinding and homogenising of solid sample materials is an important step of sample preparation. However, not all materials can be successfully processed at room temperature. Some samples, for example, must not get too warm while others are very elastic and just deform when being submitted to size reduction.


The ideal solution for thoroughly homogenising these types of samples is cryogenic grinding which involves the


use of dry ice or liquid nitrogen as grinding aid. Their cooling effect makes the sample brittle and lets it break more easily; moreover, negative effects of the frictional heat generated by the grinding process are eliminated so that, for example, volatile sample components, which are frequently the object of analysis, are preserved.


Retsch offers a wide range of laboratory mills suitable for cryogenic grinding of a large variety of materials. The CryoMill was developed specifically for this application and features an integrated cooling system. The continuous cooling of grinding jar and sample with liquid nitrogen ensures a highly effective grinding process. The operation is very safe for the user as he doesn’t come into contact with LN2 at any point.


Further Retsch mills which can be used for cryogenic grinding thanks to appropriate accessories include the Ultra Centrifugal Mill ZM 200, Mixer Mill MM 400, Cutting Mill SM 300, Knife Mill GM 300 and Mortar Grinder RM 200. Retsch has produced a number of application videos for cryogenic grinding which can be watched on the website www.retsch.com


40824pr@reply-direct.com


All the right elements...


for a perfect reaction.


WWW.LABMATE-ONLINE.COM ht *Average Pass-on rate = 3.2 Print, Online and Digital Media combined to reach 500,000 readers* 5575ad@reply-direct.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44